Philip Duong

Philip Duong currently serves as the Head of International Business at Sino Biopharmaceutical Limited, a position held since 2024, and has been a Board Member at Karolinska Development and Treadwell Therapeutics, Inc. since 2022 and 2021, respectively. Previously, Philip held various leadership roles at Sino Biopharmaceutical Limited, including Head of Overseas Business Development and Alliance and Head of Investments, from 2020 to 2023, and served as the Head of Strategy and China Operations at invoX Pharma Limited from 2022 to 2023. Philip gained extensive experience in investment banking through positions at Deutsche Bank and Merrill Lynch from 2012 to 2020. Education was completed at the University of Toronto.